| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/29/2013 | CN101389652B T cell receptors which specifically bind to VYGFVRACL-HLA-A24 |
| 05/28/2013 | US8450580 Maize variety inbred PH11YK |
| 05/28/2013 | US8450565 Soybean cultivar 98179010 |
| 05/28/2013 | US8450472 Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof |
| 05/28/2013 | US8450465 Methods of isolating peptides using surface-free affinity purification |
| 05/28/2013 | US8450460 Single-chain TNFSF fusion polypeptides |
| 05/28/2013 | US8450459 IL-21 derivatives and variants |
| 05/28/2013 | US8450458 Recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
| 05/28/2013 | US8450457 T1R taste receptors and genes encoding same |
| 05/28/2013 | US8450454 Compositions for inhibiting ABAD/ABeta protein interaction |
| 05/28/2013 | US8450289 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 05/28/2013 | US8450282 Anionic polymer, polyion complex and ternary polymer composite using anionic polymer, and pharmaceutical composition |
| 05/28/2013 | US8450280 Activation of peptide prodrugs by hK2 |
| 05/28/2013 | US8450273 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 05/28/2013 | US8450272 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 05/28/2013 | US8450271 Peptide-based scaffolds for cartilage regeneration and methods for their use |
| 05/28/2013 | US8450269 Long-acting growth hormone and methods of producing same |
| 05/28/2013 | US8450267 GRG23 EPSP synthases: compositions and methods of use |
| 05/28/2013 | US8450247 Cell display libraries |
| 05/28/2013 | US8450100 Collagen peptide having immune-enhancing activity from Cyanea nozakii and preparation method and uses thereof |
| 05/28/2013 | US8450099 Process for producing thioredoxin by stressing yeast cells |
| 05/28/2013 | US8450096 Polypeptides having phytase activity and polynucleotides encoding same |
| 05/28/2013 | US8450087 Use of triplex structure DNA in transferring nucleotide sequences |
| 05/28/2013 | US8450060 Lafora's disease gene |
| 05/28/2013 | US8449894 Aspergillus vaccine preparation and methods of making and using thereof |
| 05/28/2013 | US8449892 S. agalactiae antigens I and II |
| 05/28/2013 | US8449891 Recombinant flagellin protein and preparation and use thereof |
| 05/28/2013 | US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 05/28/2013 | US8449872 Polymer conjugates of nesiritide peptides |
| 05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
| 05/28/2013 | CA2693274C Peptide acceptor ligation methods |
| 05/28/2013 | CA2671797C Microbial process for production of enzymes |
| 05/28/2013 | CA2629821C Production of recombinant collagen like proteins |
| 05/28/2013 | CA2603374C Use of hydrophobin as a phase stabiliser |
| 05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/28/2013 | CA2586344C G protein coupled receptor agonists and antagonists and methods of use |
| 05/28/2013 | CA2554784C Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/28/2013 | CA2529282C Recombinant igf expression systems |
| 05/28/2013 | CA2517258C Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 05/28/2013 | CA2491946C Ghrelin analogs |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2459367C Methods for construction and screening of libraries of chemokine variants |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2434802C Isolating cells expressing secreted proteins |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2412239C Cytokine receptor zcytor17 |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
| 05/28/2013 | CA2324513C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013075117A2 Pegylated c-peptide |
| 05/23/2013 | WO2013075066A2 Proteins with improved half-life and other properties |
| 05/23/2013 | WO2013074999A1 Modified dna-binding proteins and uses thereof |
| 05/23/2013 | WO2013074861A1 Quantification of transthyretin and its isoforms |
| 05/23/2013 | WO2013074820A1 Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
| 05/23/2013 | WO2013074738A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/23/2013 | WO2013074615A1 Compositions and methods for modulating coagulation |
| 05/23/2013 | WO2013074489A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | WO2013073760A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase |
| 05/23/2013 | WO2013073706A1 Ligand having three-finger structure, and method for detecting molecule using same |
| 05/23/2013 | WO2013073698A1 Cxcr4 activity inhibiting peptide and application thereof |
| 05/23/2013 | WO2013073219A1 Method for producing insoluble aggregate of neurodegenerative-disease-related protein |
| 05/23/2013 | WO2013073191A1 Therapeutic agent for early delivery or abortion using plasminogen activator inhibitor-1 |
| 05/23/2013 | WO2013072946A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection |
| 05/23/2013 | WO2013072914A2 Plant rad52 and uses thereof |
| 05/23/2013 | WO2013072901A2 Compositions and methods for treating glioma |
| 05/23/2013 | WO2013072636A1 Peptides that inhibit the interaction between asf1 and histones, and use thereof |
| 05/23/2013 | WO2013072587A1 Use of fibromodulin and lumican for increasing muscle mass |
| 05/23/2013 | WO2013072542A1 Adjuvant effect of the vaccinia virus a27 protein (14k) and the use thereof in vaccines |
| 05/23/2013 | WO2013072504A1 Crystal structure of the procollagen iii c-propeptide trimer and applications thereof |
| 05/23/2013 | WO2013072381A1 Diagnosis of sepsis and systemic inflammatory response syndrome |
| 05/23/2013 | WO2013071883A1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 05/23/2013 | WO2013071678A1 Liver cancer polypeptide marker antigen competitive enzyme-linked immunosorbent assay kit |
| 05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | WO2013071396A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | WO2013071356A1 Collagen-like silk genes |
| 05/23/2013 | WO2013048116A3 Erythropoietin-derived peptide and use therefor |
| 05/23/2013 | WO2013039996A4 Compositions and methods for brown fat induction and activity using fndc5 |
| 05/23/2013 | WO2013037841A3 Chimeric non-integrating lentiviral genomes as vaccines against hiv-1 |
| 05/23/2013 | WO2012175410A9 Conditional knockout mutants of sortilin-like receptor in apicomplexan parasites and uses thereof |
| 05/23/2013 | WO2012142113A8 Isopeptide bond formation in bacillus species and uses thereof |
| 05/23/2013 | US20130133106 Isolated polynucleotides and methods and plants using same for regulating plant acidity |
| 05/23/2013 | US20130133102 Targeting signal for integrating proteins, peptides and biological molecules into bacterial microcompartments |
| 05/23/2013 | US20130133089 High affinity leptins and leptin antagonists |
| 05/23/2013 | US20130131322 Antibody being capable of binding to transforming growth factor alpha and having growth-suppressing activity on cancers having ras gene mutation |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131311 Aziridine mediated native chemical ligation |
| 05/23/2013 | US20130130993 Pimap39 modulates inflammatory response |
| 05/23/2013 | US20130130988 Macromolecular complex of bacterial origin and use of said macromolecular complex for preventing and treating inflammatory rheumatism |
| 05/23/2013 | US20130130987 Methods for inhibiting immune complex formation in a subject |
| 05/23/2013 | US20130130983 Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| 05/23/2013 | US20130130980 Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by Intraceptors |
| 05/23/2013 | US20130130979 Peptides that bind to the erythropoietin receptor |
| 05/23/2013 | US20130130977 Polymer-based sustained release device |
| 05/23/2013 | US20130130976 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases |
| 05/23/2013 | US20130130394 Devices and methods for controlling actin filaments growth and organization using micropatterned nucleation sites |
| 05/23/2013 | US20130130349 Cooperative and dynamic assembly of affinity complexes |
| 05/23/2013 | US20130130315 Fusion protein |
| 05/23/2013 | US20130130314 Expression of Proteins in Plants |